By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    physical health
    5 Ways Playing Games Can Improve Neural and Physical Health
    September 9, 2022
    Reasons For Hair Loss and Its Treatment
    Reasons For Hair Loss and Its Treatment
    February 16, 2022
    healthcare organization
    5 Actionable Strategies For Healthcare Organizations
    August 15, 2022
    Latest News
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
    The Hidden Impact Of Stress On Your Body’s Alignment And Balance
    May 22, 2025
    Chewing Matters More Than You Think: Why Proper Chewing Supports Better Health
    May 22, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Obamacare vs. Romneycare
    October 11, 2012
    HIMSS recap
    HIMSS Privacy and Security Forum: Managing Social Media While Protecting Privacy and Security
    September 12, 2014
    Almost Anybody Qualifies for Medicaid in Maine
    November 23, 2012
    Latest News
    Strengthening Healthcare Systems Through Clinical and Administrative Career Development
    June 13, 2025
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: When a Health Care Business Model Disruption is Self-Destructive
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > When a Health Care Business Model Disruption is Self-Destructive
DiagnosticsMedical InnovationsMobile HealthPolicy & LawRemote DiagnosticsWellness

When a Health Care Business Model Disruption is Self-Destructive

David Davidovic
Last updated: November 13, 2015 2:07 pm
David Davidovic
Share
5 Min Read
SHARE

Some time ago, I wrote an article here on the Uberization of Healthcare and how silly that expression is. In essence, I tried to tamper the enthusiasm behind so many healthcare start-ups wanting to disrupt the whole system but having weak premises with which to do so.

Three companies have recently gained notoriety in the healthcare space. Each openly expressing their desire and plans to disrupt everything based on completely new business models – at least that’s what they said.

Valeant:

Some time ago, I wrote an article here on the Uberization of Healthcare and how silly that expression is. In essence, I tried to tamper the enthusiasm behind so many healthcare start-ups wanting to disrupt the whole system but having weak premises with which to do so.

More Read

stress management for healthcare workers
Tips to Find Work-Life Balance in the Healthcare Profession
HIPAA for Web and Mobile Developers and Designers
Are All Dental Crowns The Same?
Infographic: App Overload for Doctors
The Uneasy Case Against Free Market Health Care

Three companies have recently gained notoriety in the healthcare space. Each openly expressing their desire and plans to disrupt everything based on completely new business models – at least that’s what they said.

Valeant:

To be fair, Valeant is a hugely successful pharmaceutical company that seemingly came out of nowhere. They grew very quickly through a long and rapid series of acquisitions. The novelty in their model is that they don’t believe in or need to do any research, which is costly but considered a critical capability in the biopharma sector.

This model works well as long as you keep growing by buying other companies and products, by consolidating operations and cutting costs, by raising prices much faster than inflation and, as they have been accused of doing, by manipulating market channels to their advantage.

The problem is that this is not sustainable in the long run. As we are seeing now and has been reported eslewhere, Valeant is facing huge headwinds as intricacies of their model and possible questionable practices, including pricing, come to light. In addition, at some point you do run out of companies and products to buy – at least at a reasonable price – and without any research, the house of cards starts to fall.

No, they have not invented a new pharma business model.  The model still requires product innovation, volume growth, transparency and respect for regulations.

Theranos:

This little company, started and run by a very smart and ambitious Stanford drop-out visionary with incredible political connections and no healthcare experience, is making a lot of waves. They promised a new business model for diagnostics based on a new proprietary and secret technology that allows many lab tests to be performed with as little as one drop of blood. 

Their model was to disupt the whole diagnostics market. Their approach included maintaining secrecy over their science and methods. Their strategy included not having a single senior scientific member on their board.

Well, sooner or later you do have to face external scrutiny.  The FDA and others, including their retail partners, have started asking questions, and the answers continue to be, “you’ll see, we’ll be releasing all that soon.” In reality, most of the tests that they have been running (all but one) have been done using the same old technolgies and methods.

No, they have not invented a new diagnostics business model. The model still requires science, peer review, and regulatory scrutiny.

Turing

This start-up has become the face of greed, run by an ambitious former hedgefund manager with no experience in the industry or in anything resembling a business with a heart. His business model: buy old products sold for little money and turn around and sell them for a fortune. His model in action: taking an $18 pill drug and overnight change the price to $750.

Not sure if he expected to be able to do this under the radar and not be noticed, but he’s gotten a lot of attention, including from the U.S. Senate. In the process, he has attracted a lot of unwanted attention to the industry, undoing years of value-driven actions and communication efforts. 

No, Turing did not invent a new pharmaceutical business model. The model still requires a justification for prices and price increases as well as sensitivity for customers and patient.

These are three examples of industry disrupter-wannabes who, by ignoring fundamentals, have entered a path of self-destruction.

 

TAGGED:Business ModelethicspharmaceuticalTheranosTuringValeant
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Transcranial Magnetic Stimulation (TMS) Therapy
How TMS Therapy Helps with Treatment-Resistant Mental Illness
Mental Health Therapies
June 13, 2025
Strengthening Healthcare Systems Through Clinical and Administrative Career Development
Global Healthcare Policy & Law
June 11, 2025
magnesium supplements
The Wide-Ranging Benefits of Magnesium Supplements
Health
June 11, 2025
preparing for next pendamic
Preparing for the Next Pandemic: How Technology is Changing the Game
Technology
June 6, 2025

You Might also Like

Health careSpecialtiesWellness

Top Three Essentials for General Health Care during Pregnancy

January 13, 2019
Image
eHealthMobile Health

Mobile Apps for Chronic Cancer Patients

February 19, 2014

What’s Next for “Chronic” Cancer Patients?

December 8, 2014
SpecialtiesWellness

Zinc and Testosterone – Does Zinc Support Testosterone Levels?

June 29, 2019
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?